Axsome Therapeutics, Inc.

US$132.37As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AXSMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 34.68%
Div yield —
ROE (175.59%)
Biotechnology
Beta (5Y) 0.83
PE TTM —
TSR TTM (1.94%)
Mkt cap US$6.963B
ROIC (32.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$127
(3.68%)
172.28%
Hold 10|7|1|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.43
1.54
1.65
1.68
13.94%
10.82%
14.62%
15.44%
Revenue$M
788.2
799.4
786.6
763.8
0.87%
5.25%
1.00%
(3.87%)
Peers (US$6.963B)
Cap (US$)
PE
7.236B
75.71x
6.787B
—
6.899B
5.173x
Capital
TTM
5Y
10Y
Leveragex
2.505
(0.068)
(0.041)
EBIT/Intx
3.435
0.396
0.364
Own earn%
130.93
22.84
21.10
Sh yield%
48.97
63.36
63.94
Owners
Insiders/Inst%
2.94
44.39
Short interest%
3.36
SBC / revenue%
2.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
29–35
$1 testx
—
Incr. ROIC%
6